MAG
CEMI

Millrace Asset Group’s Chembio diagnostics, Inc. CEMI Stock Holding History

Millrace Asset Group’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-163,856
Closed -$839K – 93
2020
Q1 		$839K Buy
+163,856
New +$663K 1.27% 47
2019
Q4 		– Sell
-148,249
Closed -$907K – 79
2019
Q3 		$907K Sell
148,249
-54,348
-27% -$324K 1.06% 49
2019
Q2 		$1.23M Sell
202,597
-78,128
-28% -$527K 1.28% 46
2019
Q1 		$1.56M Buy
280,725
+40,499
+17% +$263K 1.31% 45
2018
Q4 		$1.36M Buy
+240,226
New +$1.77M 1.25% 46

Other funds holding CEMI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millrace Asset Group's CEMI Position: Q2 2020 in Review

Millrace Asset Group sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2020, closing a stake of 163,856 shares — an estimated $839K sold.

Millrace Asset Group first reported a position in CEMI in Q4 2018 and held it in 5 quarters. The position peaked at $1.56M in Q1 2019. 76 funds tracked by Wall St. Rank hold CEMI as of Q2 2020.

  • Millrace Asset Group reported no remaining Chembio diagnostics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Millrace Asset Group sold 163,856 Chembio diagnostics, Inc. shares in Q2 2020, an estimated $839K.
  • Millrace Asset Group first reported a position in Chembio diagnostics, Inc. in Q4 2018 and held it in 5 quarters.
  • Millrace Asset Group's Chembio diagnostics, Inc. position peaked at $1.56M in Q1 2019.
  • 76 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2020.

Based on Millrace Asset Group's 13F filing for Q2 2020, filed 13 Aug 2020.